Clinical Trial Update: Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating safety and efficacy of expanded allogeneic adipose-derived mesenchymal stromal cells in patients with moderate t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Expanded allogeneic adipose-derived mesenchymal stromal cells (adipose-derived mesenchymal stromal cells)

Snippet

Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine | Conditions: Mesenchymal Stromal Cells, Psoriasis | Phase 1, Phase 2 | Status: COMPLETED